Growth Metrics

Protalix BioTherapeutics (PLX) Other Gross PP&E Adjustments (2011 - 2026)

Protalix BioTherapeutics' quarterly Other Gross PP&E Adjustments came in at -$7.8 million in Q1 2026, down 49.15% year-on-year from -$15.3 million in Q1 2025, and down 122.77% quarter-over-quarter from $34.2 million in Q4 2025.

Protalix BioTherapeutics has reported Other Gross PP&E Adjustments for 16 years, with the latest figure at -$7.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 49.15% year-over-year to -$7.8 million; the trailing twelve-month figure through Mar 2026 stood at -$7.8 million (down 49.15% YoY), and the FY2025 full-year result was $34.2 million, down 1.93% from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at -$7.8 million, down from $34.2 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $34.9 million in Q4 2024, with the low at -$7.8 million in Q3 2025.
  • Average Other Gross PP&E Adjustments over 5 years is $3.6 million, with a median of -$5.2 million recorded in 2023.
  • Year-over-year, Other Gross PP&E Adjustments increased 12.79% in 2025 and slumped 49.15% in 2026.
  • Tracing PLX's Other Gross PP&E Adjustments over 5 years: stood at $33.2 million in 2022, then rose by 1.81% to $33.8 million in 2023, then advanced by 3.4% to $34.9 million in 2024, then declined by 1.93% to $34.2 million in 2025, then slumped by 122.77% to -$7.8 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at -$7.8 million (Q1 2026), $34.2 million (Q4 2025), and -$7.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn -7.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.79 Mn
Mar 31, 2026 -7.79 Mn
Dec 31, 2025 34.23 Mn
Dec 31, 2025 34.23 Mn
Sep 30, 2025 -7.81 Mn
Sep 30, 2025 -7.81 Mn
Jun 30, 2025 -5.00 Mn
Jun 30, 2025 -5.00 Mn
Mar 31, 2025 -5.23 Mn
Mar 31, 2025 -5.23 Mn
Dec 31, 2024 34.90 Mn
Dec 31, 2024 34.90 Mn
Sep 30, 2024 -5.65 Mn
Sep 30, 2024 -5.65 Mn
Jun 30, 2024 -5.73 Mn
Jun 30, 2024 -5.73 Mn
Mar 31, 2024 -5.88 Mn
Mar 31, 2024 -5.88 Mn
Dec 31, 2023 33.75 Mn
Dec 31, 2023 33.75 Mn
Sep 30, 2023 -5.92 Mn
Sep 30, 2023 -5.92 Mn
Jun 30, 2023 -5.81 Mn
Jun 30, 2023 -5.81 Mn
Mar 31, 2023 -5.20 Mn
Mar 31, 2023 -5.20 Mn
Dec 31, 2022 33.15 Mn
Dec 31, 2022 33.15 Mn
Sep 30, 2022 -4.85 Mn
Sep 30, 2022 -4.85 Mn
Jun 30, 2022 -4.77 Mn
Jun 30, 2022 -4.77 Mn
Mar 31, 2022 -4.90 Mn
Mar 31, 2022 -4.90 Mn
Dec 31, 2021 32.75 Mn
Dec 31, 2021 32.75 Mn
Sep 30, 2021 -5.25 Mn
Sep 30, 2021 -5.25 Mn
Jun 30, 2021 -5.41 Mn
Jun 30, 2021 -5.41 Mn
Mar 31, 2021 -5.49 Mn
Mar 31, 2021 -5.49 Mn
Dec 31, 2020 31.20 Mn
Dec 31, 2020 31.20 Mn
Sep 30, 2020 -5.70 Mn
Sep 30, 2020 -5.70 Mn
Jun 30, 2020 -5.68 Mn
Jun 30, 2020 -5.68 Mn
Mar 31, 2020 -5.71 Mn
Mar 31, 2020 -5.71 Mn
Dec 31, 2019 30.30 Mn
Dec 31, 2019 30.30 Mn
Sep 30, 2019 -5.76 Mn
Sep 30, 2019 -5.76 Mn
Jun 30, 2019 -5.86 Mn
Jun 30, 2019 -5.86 Mn
Mar 31, 2019 -5.84 Mn
Mar 31, 2019 -5.84 Mn
Dec 31, 2018 35.51 Mn
Dec 31, 2018 35.51 Mn
Dec 31, 2017 35.14 Mn
Dec 31, 2017 35.14 Mn
Dec 31, 2016 34.30 Mn
Dec 31, 2016 34.30 Mn
Dec 31, 2015 33.55 Mn
Dec 31, 2015 33.55 Mn
Dec 31, 2014 32.74 Mn
Dec 31, 2014 32.74 Mn
Dec 31, 2013 32.03 Mn
Dec 31, 2013 32.03 Mn
Dec 31, 2012 31.10 Mn
Dec 31, 2012 31.10 Mn
Dec 31, 2011 29.42 Mn
Dec 31, 2011 29.42 Mn